204 related articles for article (PubMed ID: 16792582)
1. Steroid-sparing effect of subcutaneous SQ-standardised specific immunotherapy in moderate and severe house dust mite allergic asthmatics.
Blumberga G; Groes L; Haugaard L; Dahl R
Allergy; 2006 Jul; 61(7):843-8. PubMed ID: 16792582
[TBL] [Abstract][Full Text] [Related]
2. [Effect of 1-year specific immunotherapy with standardized house dust mite vaccine on mild to moderate allergic asthmatic patients].
Wang HY; Lin XP; Hao CL; Zhang CQ; Sun BQ; Zheng JP; Chen P; Sheng JY; Wu A; Zhong NS
Zhonghua Jie He He Hu Xi Za Zhi; 2006 Oct; 29(10):679-87. PubMed ID: 17129496
[TBL] [Abstract][Full Text] [Related]
3. Assessment of sublingual immunotherapy efficacy in children with house dust mite-induced allergic asthma optimally controlled by pharmacologic treatment and mite-avoidance measures.
Pham-Thi N; Scheinmann P; Fadel R; Combebias A; Andre C
Pediatr Allergy Immunol; 2007 Feb; 18(1):47-57. PubMed ID: 17295799
[TBL] [Abstract][Full Text] [Related]
4. Standardized quality (SQ) house dust mite sublingual immunotherapy tablet (ALK) reduces inhaled corticosteroid use while maintaining asthma control: a randomized, double-blind, placebo-controlled trial.
Mosbech H; Deckelmann R; de Blay F; Pastorello EA; Trebas-Pietras E; Andres LP; Malcus I; Ljørring C; Canonica GW
J Allergy Clin Immunol; 2014 Sep; 134(3):568-575.e7. PubMed ID: 24797423
[TBL] [Abstract][Full Text] [Related]
5. Effect of specific immunotherapy added to pharmacologic treatment and allergen avoidance in asthmatic patients allergic to house dust mite.
Maestrelli P; Zanolla L; Pozzan M; Fabbri LM;
J Allergy Clin Immunol; 2004 Apr; 113(4):643-9. PubMed ID: 15100667
[TBL] [Abstract][Full Text] [Related]
6. A double-blind, placebo-controlled study of house dust mite immunotherapy in Chinese asthmatic patients.
Wang H; Lin X; Hao C; Zhang C; Sun B; Zheng J; Chen P; Sheng J; Wu A; Zhong N
Allergy; 2006 Feb; 61(2):191-7. PubMed ID: 16409195
[TBL] [Abstract][Full Text] [Related]
7. [Analysis of the efficacy of specific immunotherapy with house-dust mite extracts in adults with allergic rhinitis and/or asthma].
Polzehl D; Keck T; Riechelmann H
Laryngorhinootologie; 2003 Apr; 82(4):272-80. PubMed ID: 12717603
[TBL] [Abstract][Full Text] [Related]
8. Grass pollen immunotherapy as an effective therapy for childhood seasonal allergic asthma.
Roberts G; Hurley C; Turcanu V; Lack G
J Allergy Clin Immunol; 2006 Feb; 117(2):263-8. PubMed ID: 16461125
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of a House Dust Mite Sublingual Allergen Immunotherapy Tablet in Adults With Allergic Asthma: A Randomized Clinical Trial.
Virchow JC; Backer V; Kuna P; Prieto L; Nolte H; Villesen HH; Ljørring C; Riis B; de Blay F
JAMA; 2016 Apr; 315(16):1715-25. PubMed ID: 27115376
[TBL] [Abstract][Full Text] [Related]
10. The effect of oral steroids with and without vitamin D3 on early efficacy of immunotherapy in asthmatic children.
Majak P; Rychlik B; Stelmach I
Clin Exp Allergy; 2009 Dec; 39(12):1830-41. PubMed ID: 19817753
[TBL] [Abstract][Full Text] [Related]
11. Clinical and immunologic effects of sublingual immunotherapy in asthmatic children sensitized to mites: a double-blind, randomized, placebo-controlled study.
Lue KH; Lin YH; Sun HL; Lu KH; Hsieh JC; Chou MC
Pediatr Allergy Immunol; 2006 Sep; 17(6):408-15. PubMed ID: 16925685
[TBL] [Abstract][Full Text] [Related]
12. Successful management of mite-allergic asthma with modified extracts of Dermatophagoides pteronyssinus and Dermatophagoides farinae in a double-blind, placebo-controlled study.
García-Robaina JC; Sánchez I; de la Torre F; Fernández-Caldas E; Casanovas M
J Allergy Clin Immunol; 2006 Nov; 118(5):1026-32. PubMed ID: 17088125
[TBL] [Abstract][Full Text] [Related]
13. [Clinical efficacy of a standardized specific immunotherapy against house dust mite in 85 asthmatic children].
Zhang X; Li MR; Wang C; Wang XN; Zhang HL; Lin J; Jin K; Li YC
Zhonghua Er Ke Za Zhi; 2010 Jul; 48(7):526-30. PubMed ID: 21055090
[TBL] [Abstract][Full Text] [Related]
14. Usefulness of specific immunotherapy in patients with atopic dermatitis and allergic sensitization to house dust mites: a multi-centre, randomized, dose-response study.
Werfel T; Breuer K; Ruéff F; Przybilla B; Worm M; Grewe M; Ruzicka T; Brehler R; Wolf H; Schnitker J; Kapp A
Allergy; 2006 Feb; 61(2):202-5. PubMed ID: 16409197
[TBL] [Abstract][Full Text] [Related]
15. Usefulness of specific immunotherapy in patients with severe perennial allergic rhinitis induced by house dust mite: a double-blind, randomized, placebo-controlled trial.
Varney VA; Tabbah K; Mavroleon G; Frew AJ
Clin Exp Allergy; 2003 Aug; 33(8):1076-82. PubMed ID: 12911781
[TBL] [Abstract][Full Text] [Related]
16. Comparison between the use of adsorbed and aqueous immunotherapy material in Dermatophagoides pteronyssinus sensitive asthmatic children.
Altintaş D; Akmanlar N; Güneşer S; Burgut R; Yilmaz M; Buğdayci R; Aksungur P
Allergol Immunopathol (Madr); 1999; 27(6):309-17. PubMed ID: 10611556
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of sublingual immunotherapy with high-dose mite extracts in asthma: a multi-center, double-blind, randomized, and placebo-controlled study in Taiwan.
Niu CK; Chen WY; Huang JL; Lue KH; Wang JY
Respir Med; 2006 Aug; 100(8):1374-83. PubMed ID: 16403616
[TBL] [Abstract][Full Text] [Related]
18. Double-blind and placebo-controlled study to assess efficacy and safety of a modified allergen extract of Dermatophagoides pteronyssinus in allergic asthma.
Ameal A; Vega-Chicote JM; Fernández S; Miranda A; Carmona MJ; Rondón MC; Reina E; García-González JJ
Allergy; 2005 Sep; 60(9):1178-83. PubMed ID: 16076305
[TBL] [Abstract][Full Text] [Related]
19. Effects of dermatophagoides pteronyssinus allergen-specific immunotherapy on the serum interleukin-13 and pulmonary functions in asthmatic children.
Chen ZG; Li M; Chen YF; Ji JZ; Li YT; Chen W; Chen FH; Chen H
Chin Med J (Engl); 2009 May; 122(10):1157-61. PubMed ID: 19493463
[TBL] [Abstract][Full Text] [Related]
20. Clinical effectiveness of a mite allergen-impermeable bed-covering system in asthmatic mite-sensitive patients.
van den Bemt L; van Knapen L; de Vries MP; Jansen M; Cloosterman S; van Schayck CP
J Allergy Clin Immunol; 2004 Oct; 114(4):858-62. PubMed ID: 15480327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
